Clinical Trial Update: Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating immune monitoring and calcineurin inhibitor withdrawal in low-risk kidney transplant recipients was terminated, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Recipients

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplant Recipients | Phase 2 | Status: TERMINATED | Results posted: 2016-11-30